Abrezekimab, a novel drug, is generating significant excitement within the scientific community as a potential option for managing a spectrum of inflammatory diseases. This monoclonal antibody works by https://abrezekimab948157.aboutyoublog.com/53979931/abrezekimab-a-potential-breakthrough-for-chronic-diseases